Calypso Biotech SA

Calypso Biotech, a Dutch company developing treatments for autoimmune diseases was acquired by Novartis in January 2024.

Overview Structured Data Issues Contributors

calypsobiotech.com

Is a

Organization

Company

Company attributes

Industry

Biotechnology

Engineering

Biomedical engineering

Location

Netherlands

B2X

B2C

AngelList URL

angel.co/calypso-biotech-sa

Pitchbook URL

linkedin.com/company/...-biotech/

Investors

Inkef Capital

M Ventures

Gilde Healthcare

Merck Serono Ventures (M Ventures)

Eclosion SA

Johnson & Johnson Innovation

Total Funding Amount (USD)

22,700,000

Latest Funding Round Date

February 2019

Acquisition Transaction

‌

Acquisition of Calypso Biotech BV by Novartis

Latest Funding Type

Series A

Patents Assigned (Count)

Wellfound ID

calypso-biotech-sa

Country

Netherlands

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Calypso Biotech SA

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.